Study identifier:NIS-GAT-NEX-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
LIFE NIS, GERD-Patients - Evaluation of Burden of Disease determined by GERD impact scale (GIS)
GERD
-
No
-
All
900
Observational
N/A
Allocation: - 
Endpoint Classification: - 
Intervention Model: - 
Masking: - 
Primary Purpose: - 
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
| Arms | Assigned Interventions | 
|---|